Anne F. Gilliam

Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists

Brian F. Thomas, Anne F. Gilliam, David F. Burch et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 242 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Synthesis and Structure−Activity Relationships of Amide and Hydrazide Analogues of the Cannabinoid CB₁ Receptor Antagonist <i>N</i>-(Piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1<i>H</i>-pyrazole-3-carboxamide (SR141716)

Ma. Elena Y. Francisco, Herbert H. Seltzman, Anne F. Gilliam et al. · Journal of Medicinal Chemistry · 2002 · 87 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain

Herbert H. Seltzman, Craig Shiner, Erin E. Hirt et al. · Journal of Medicinal Chemistry · 2016 · 74 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Synthesis and Biological Evaluation of Bivalent Ligands for the Cannabinoid 1 Receptor

Yanan Zhang, Anne F. Gilliam, Rangan Maitra et al. · Journal of Medicinal Chemistry · 2010 · 66 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The Bioactive Conformation of Aminoalkylindoles at the Cannabinoid CB1 and CB2 Receptors:  Insights Gained from (<i>E</i>)- and (<i>Z</i>)-Naphthylidene Indenes

Patricia H. Reggio, Sharmista Basu-Dutt, Judy Barnett‐Norris et al. · Journal of Medicinal Chemistry · 1998 · 62 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15